Clinical Trials · NCT02381288
Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- Takeda
- Enrollment
- 17
- Start date
- Sep 2015
- Locations
- 1 site, United States
- Primary endpoint
- Percent Change From Baseline in Average Serum Concentration (Cav) of Total ST After 6 Weeks of Dosing